The combination of the MHRA Accreditation and the expert knowledge of conducting 500 Early Phase Studies ensure Richmond Pharmacology can provide you with a service that meets your needs.
Adaptive Phase I Studies
Rapid approval, flexible conduct, adaptive protocols in a MHRA accredited facility.
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
.svg){kind=small}
